TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
2021 · Cancers · 8 citations
https://doi.org/10.3390/cancers13215502
Y
Ying Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
638
Citations
12
h-index
16
i10-index
Ying Liu is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research. The author has an h-index of 12, co-authored 49 publications.
ORCID: 0000-0002-9167-3205Papers by this author
worksQuantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms
2023 · Journal of Molecular Diagnostics · 3 citations
https://doi.org/10.1016/j.jmoldx.2023.11.009
1234 Immunohistochemical Staining for RAS Q61R Mutation in B-cell Lymphoproliferative Disorders Identifies Mutated Subclones
2025 · Laboratory Investigation · 0 citations
https://doi.org/10.1016/j.labinv.2024.103470
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat